PICO Portalanswers from OpenAlex
NYU Langone Health
InstitutionResearch output, impact & collaborations
NYU Langone Health is a institution indexed in PICO Portal from OpenAlex.
What is known about NYU Langone Health?
PICO Portalrecord summary
NYU Langone Health is a research organisation in New York, US. OpenAlex records 39,238 works and 3,031,405 citations for it. 9,185 researchers list it as their most recent affiliation.
How many works does NYU Langone Health have?
PICO Portalindexed works
NYU Langone Health has 39,238 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does NYU Langone Health have?
PICO Portalcitation count
NYU Langone Health has 3,031,405 citations in the OpenAlex counts PICO Portal stores.
How many researchers are at NYU Langone Health?
PICO Portalresearcher count
NYU Langone Health has 9,185 researchers in the PICO Portal index.
What is the average h-index at NYU Langone Health?
PICO Portalavg h-index
NYU Langone Health has an average h-index of 70.2 in OpenAlex.
What is the ROR of NYU Langone Health?
PICO Portalror
The ROR for NYU Langone Health is on the source record.
What is the OpenAlex record for NYU Langone Health?
PICO Portalopenalex
The OpenAlex for NYU Langone Health is on the source record.
Who are the most-cited researchers behind NYU Langone Health?
PICO Portaltop researchers by citations
What are the most-cited papers on NYU Langone Health?
PICO Portalmost cited works
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary
Elliott M. Antman, Daniel T. Anbe, Paul W. Armstrong, Eric Bates, Lee A. Green, Mary M. Hand, Judith S. Hochman, Harlan M. Krumholz, Frederick G. Kushner, Gervasio A. Lamas, Charles J. Mullany, Joseph P. Ornato, David L. Pearle, Michael A. Sloan, Sidney C. Smith, Elliott M. Antman, Sidney C. Smith, Joseph S. Alpert, Jeffrey L. Anderson, David P. Faxon, Valentı́n Fuster, Raymond J. Gibbons, Gabriel Gregoratos, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Alice K. Jacobs, Joseph P. Ornato
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J. Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa Ho, Martin L. Miller, Natasha Rekhtman, André L. Moreira, Fawzia K. Ibrahim, Cameron Bruggeman, Billel Gasmi, Roberta Zappasodi, Yuka Maeda, Chris Sander, Edward B. Garon, Taha Merghoub, Jedd D. Wolchok, Ton N. Schumacher, Timothy A. Chan
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic, Meg Jardine, Bruce Neal, Séverine Bompoint, Hiddo J.L. Heerspink, David M. Charytan, Robert Edwards, Rajiv Agarwal, George L. Bakris, Scott Bull, Christopher P. Cannon, George Capuano, Pei-Ling Chu, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol A. Pollock, David C. Wheeler, Yshai Yavin, Hong Zhang, Bernard Zinman, Gary Meininger, Barry M. Brenner, Kenneth W. Mahaffey
ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations
Eugene Braunwald, Elliott M. Antman, John W. Beasley, Robert M. Califf, Melvin D. Cheitlin, Judith S. Hochman, Robert H. Jones, Dean J. Kereiakes, Joel Kupersmith, Thomas N. Levin, Carl J. Pepine, John W. Schaeffer, Earl E. Smith, David E. Steward, Pierre Théroux, Raymond J. Gibbons, Joseph S. Alpert, Kim A. Eagle, David P. Faxon, Valentı́n Fuster, Timothy J. Gardner, Gabriel Gregoratos, Richard O. Russell, Sidney C. Smith
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert, L. Thomas, Igor Bondarenko, Steven O’Day, Jeffrey S. Weber, Claus Garbe, Célèste Lebbé, Jean‐François Baurain, Alessandro Testori, Jean‐Jacques Grob, Neville Davidson, Jon Richards, Michele Maio, Axel Hauschild, Wilson H. Miller, Pere Gascón, Michal Lotem, Kaan Harmankaya, Ramy Ibrahim, Stephen Francis, Tai‐Tsang Chen, Rachel Humphrey, Axel Hoos, Jedd D. Wolchok
How much of the research on NYU Langone Health is open access?
PICO Portalopen access share
67%OPEN ACCESS